Trainings By Informa Markets

Interchangeability and adaptation in biosimilar development: Where do we stand?

Duration - 24 Minutes

About the course

Regulatory approaches toward interchanging biosimilars
• What should we expect from FDA''s Biosimilar Interchangeability Guidelines
• Better picture of biosimilar safety and efficacy

Speaker Profile

Dr. Sarfaraz K. Niazi

Adjunct Professor - University of Illinois and University of Houston and Founder
Karyo Biologics, Adello Biologics and Pharmaceutical Scientist Inc.

Website by: Xpoteck